Literature DB >> 28722573

Killing of Cryptosporidium sporozoites by Lactoferrin.

Jose Luis Paredes1, Hayley Sparks2, A Clinton White2, Griselle Martinez-Traverso2, Theresa Ochoa1, Alejandro Castellanos-González2.   

Abstract

Intestinal infection caused by Cryptosporidium is a major contributor to diarrhea morbidity and mortality in young children around the world. Current treatments for children suffering from cryptosporidiosis are suboptimal. Lactoferrin is a glycoprotein found in breast milk. It has showed bacteriostatic and antimicrobial activity in the intestine. However, the effects of lactoferrin on the intestinal parasite Cryptosporidium have not been reported. In this study, we investigated the anticryptosporidial activity of human lactoferrin on different stages of Cryptosporidium. Physiologic concentrations of lactoferrin killed Cryptosporidium parvum sporozoites, but had no significant effect on oocysts viability or parasite intracellular development. Since sporozoites are essential for the infection process, our data reinforce the importance of breastfeeding and point to the potential of lactoferrin as a novel therapeutic agent for cryptosporidiosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28722573      PMCID: PMC5590577          DOI: 10.4269/ajtmh.16-0804

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

Review 1.  Antiinflammatory activities of lactoferrin.

Authors:  O M Conneely
Journal:  J Am Coll Nutr       Date:  2001-10       Impact factor: 3.169

2.  Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance.

Authors:  A Aguila; A G Herrera; D Morrison; B Cosgrove; A Perojo; I Montesinos; J Pérez; G Sierra; C G Gemmell; J H Brock
Journal:  FEMS Immunol Med Microbiol       Date:  2001-08

3.  Bactericidal effect of lactoferrin on Legionella pneumophila.

Authors:  C A Bortner; R D Miller; R R Arnold
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

4.  Human milk inactivates pathogens individually, additively, and synergistically.

Authors:  Charles E Isaacs
Journal:  J Nutr       Date:  2005-05       Impact factor: 4.798

Review 5.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

6.  Cryptosporidium infection of human intestinal epithelial cells increases expression of osteoprotegerin: a novel mechanism for evasion of host defenses.

Authors:  Alejandro Castellanos-Gonzalez; Linda S Yancey; Heuy-Ching Wang; Birte Pantenburg; Kathleen R Liscum; Dorothy E Lewis; A Clinton White
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

7.  A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.

Authors:  Alejandro Castellanos-Gonzalez; A Clinton White; Kayode K Ojo; Rama S R Vidadala; Zhongsheng Zhang; Molly C Reid; Anna M W Fox; Katelyn R Keyloun; Kasey Rivas; Ayesha Irani; Sara M Dann; Erkang Fan; Dustin J Maly; Wesley C Van Voorhis
Journal:  J Infect Dis       Date:  2013-07-21       Impact factor: 5.226

8.  Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward.

Authors:  Hayley Sparks; Gayatri Nair; Alejandro Castellanos-Gonzalez; A Clinton White
Journal:  Curr Trop Med Rep       Date:  2015-08-01

9.  Natural History of Cryptosporidiosis in a Longitudinal Study of Slum-Dwelling Bangladeshi Children: Association with Severe Malnutrition.

Authors:  Poonum S Korpe; Rashidul Haque; Carol Gilchrist; Cristian Valencia; Feiyang Niu; Miao Lu; Jennie Z Ma; Sarah E Petri; Daniel Reichman; Mamun Kabir; Priya Duggal; William A Petri
Journal:  PLoS Negl Trop Dis       Date:  2016-05-04

10.  Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality.

Authors:  David A Shoultz; Eugenio L de Hostos; Robert K M Choy
Journal:  PLoS Negl Trop Dis       Date:  2016-01-28
View more
  3 in total

Review 1.  Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.

Authors:  Daniela Zarzosa-Moreno; Christian Avalos-Gómez; Luisa Sofía Ramírez-Texcalco; Erick Torres-López; Ricardo Ramírez-Mondragón; Juan Omar Hernández-Ramírez; Jesús Serrano-Luna; Mireya de la Garza
Journal:  Molecules       Date:  2020-12-08       Impact factor: 4.411

Review 2.  Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides.

Authors:  Špela Gruden; Nataša Poklar Ulrih
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 3.  Activity of Apo-Lactoferrin on Pathogenic Protozoa.

Authors:  Magda Reyes-López; Gerardo Ramírez-Rico; Jesús Serrano-Luna; Mireya de la Garza
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.